Literature DB >> 6315212

Correlations between cytologic composition and biologic behavior in the glioblastoma multiforme. A postmortem study of 50 cases.

F Giangaspero, P C Burger.   

Abstract

The brains of 50 adults with supratentorial glioblastoma multiforme were studied post mortem. The cytologic compositions of the neoplasms were examined in each of three sites: (1) in and around the original tumor bed; (2) zones of infiltration of contiguous structures; and (3) implants in the subarachnoid and/or ventricular spaces. For this purpose, six different cell types were defined: small anaplastic cells (SAC), small fibrillated cells (SFC), fibrillated astrocytes (FA), pleomorphic astrocytes (PA), gemistocytic astrocytes (GA), and large bizarre cells (LBC). In 16 cases with marked mass effect in the original tumor bed entirely due to the neoplasm, the cytologic composition of the neoplasm was predominantly SAC (14 cases) and SFC (2 cases). The prevalence of these two cellular types was evident in the infiltrated regions in 36 of 42 cases, and in the metastatic foci of 11 of 13 cases. In 10 of 11 cases in which there was mild or no mass effect, only limited infiltration in the ipsilateral hemisphere, and no metastases, the neoplasms were composed of a combination of FA, PA, GA, and LBC. The observations suggest that, in spite of the glioblastoma's cytologic heterogeneity, the pathologic substrate of aggressiveness in this malignant glioma is related largely to the proliferation of a population of small anaplastic cells. On the basis of this observation, as well as the consideration of certain clinical and therapeutic variables, an outline is presented summarizing the history of the glioblastoma multiforme from treatment until the time of death.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6315212     DOI: 10.1002/1097-0142(19831215)52:12<2320::aid-cncr2820521227>3.0.co;2-n

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  17 in total

1.  Oligoastrocytomas: a clinicopathological study of 52 cases.

Authors:  H G Krouwer; S G van Duinen; W Kamphorst; P van der Valk; A Algra
Journal:  J Neurooncol       Date:  1997-07       Impact factor: 4.130

Review 2.  Definition and diagnostic implications of gemistocytic astrocytomas: a pathological perspective.

Authors:  Tarik Tihan; Poonam Vohra; Mitchel S Berger; G Evren Keles
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

3.  Continuous human glioma-derived cell lines UC-11MG and UC-302MG. Morphologic, immunocytochemical and chromosomal characterization.

Authors:  B H Liwnicz; G Archer; S W Soukup; R G Liwnicz
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

4.  Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells.

Authors:  T Abe; T Mori; K Kohno; M Seiki; T Hayakawa; H G Welgus; S Hori; M Kuwano
Journal:  Clin Exp Metastasis       Date:  1994-07       Impact factor: 5.150

5.  Suppression of Cdc2 dephosphorylation at the tyrosine 15 residue during nitrosourea-induced G2M phase arrest in glioblastoma cell lines.

Authors:  Akira Nakamizo; Takanori Inamura; Satoshi Inoha; Toshiyuki Amano; Hirofumi Ochi; Kiyonobu Ikezaki; Masashi Fukui
Journal:  J Neurooncol       Date:  2002-08       Impact factor: 4.130

6.  Growth fraction in human brain tumors defined by the monoclonal antibody Ki-67.

Authors:  F Giangaspero; C Doglioni; M T Rivano; S Pileri; J Gerdes; H Stein
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

Review 7.  The cause of death in patients with glioblastoma is multifactorial: clinical factors and autopsy findings in 117 cases of supratentorial glioblastoma in adults.

Authors:  D L Silbergeld; R C Rostomily; E C Alvord
Journal:  J Neurooncol       Date:  1991-04       Impact factor: 4.130

8.  Invasiveness of human glioma cell lines in vitro: relation to tumorigenicity in athymic mice.

Authors:  L I de Ridder; O D Laerum; S J Mørk; D D Bigner
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

9.  Histologic factors in the grading and prognosis of astrocytoma grade I-IV.

Authors:  E H Rutten; W H Doesburg; J L Slooff
Journal:  J Neurooncol       Date:  1992-07       Impact factor: 4.130

10.  The proliferation rate of intracranial tumors as defined by the monoclonal antibody KI 67. Application of the method to paraffin embedded specimens.

Authors:  D K Böker; H J Stark
Journal:  Neurosurg Rev       Date:  1988       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.